Accor (WBO:AC) Research & Development: €0 Mil (TTM As of Dec. 2025)


WBO:AC Accor SA WBO:AC
80 GF Score
Price €49.80
GF Value €54.12
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Accor Research & Development?

Accor WBO:AC +1.61% 80 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates WBO:AC with a GF Score™ of 80/100 and a GF Value™ of €54.12 (Fairly Valued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Accor's Research & Development for the six months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Accor  (WBO:AC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Accor Research & Development Related Terms

Accor Research & Development Historical Data

* Premium members only.

The historical data trend for Accor's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accor Research & Development Chart

Accor Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Accor Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WBO:AC
80GF Score
Accor SA WBO:AC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accor Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Accor (WBO:AC) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Accor and its competitors.
Is Accor's Research & Development too high?
Accor's current Research & Development is €0 Mil. Overall, Accor has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Accor's Research & Development compare to MAR and HLT?
Accor's Research & Development of €0 Mil can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Travel & Leisure company?
A good Research & Development depends on the Travel & Leisure industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Accor and its competitors. Accor's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accor stock overvalued right now?
Based on GuruFocus' analysis, Accor (WBO:AC) is currently considered Fairly Valued. The stock's GF Value™ is €54.12, compared to a current price of €49.80 — trading 8% below its estimated fair value. The current Research & Development is €0 Mil. Accor's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Accor (WBO:AC), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accor (WBO:AC) Overvalued in 2026?

Based on GuruFocus' analysis, Accor stock appears to be undervalued. The current stock price of €49.80 is trading 8% below its estimated GF Value™ of €54.12. GuruFocus considers Accor to be Fairly Valued.

Key valuation signals for WBO:AC:

  • Research & Development: €0 Mil
  • GF Value™: €54.12 vs. price of €49.80 (8% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the WBO:AC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accor Business Description

Address 82, Rue Henri Farman, Tour Sequana, Issy-les-Moulineaux, Paris, FRA, 92130
Accor operates 881,427 rooms across 48 brands, addressing the economy through luxury segments as of December 2025. Ibis (economy scale) is the largest brand (33% of total rooms at the end of 2025), followed by midscale brands Mercure (16%) and Novotel (13%). FRHI offers additional luxury and North American exposure. After the sale of the majority of HotelInvest (owned assets) in 2018-19, the majority of total EBITDA comes from asset-light managed and franchised hotels. Europe and North Africa represent 41% of rooms, Asia-Pacific 36%, the Americas 12%, and India, Middle East, and Africa 11%. Premium, midscale, and economy are 84% of total rooms, while luxury and lifestyle are the remaining 16%.
80GF Score

Get the complete analysis for WBO:AC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€49.80
Price
€54.12
GF Value